Overview
Marisa Ojala practices practicing medicine in Tampere, Finland.
Her clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM) and Cardiomyopathy.
She is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Marisa Ojala
Is Marisa Ojala a top-rated expert for Hypertrophic Cardiomyopathy (HCM)?
MediFind is an objective health platform that identifies experts based on real-world data. Marisa Ojala is classified as an Experienced expert for Hypertrophic Cardiomyopathy (HCM), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Marisa Ojala participate in research or clinical trials?
Yes. Marisa Ojala has published 11 articles and abstracts on conditions like Hypertrophic Cardiomyopathy (HCM). You can view a list of Marisa Ojala's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CardiomyopathyMs. Ojala isExperienced. Learn about Cardiomyopathy.
- Hypertrophic Cardiomyopathy (HCM)Ms. Ojala isExperienced. Learn about Hypertrophic Cardiomyopathy (HCM).